Cargando…
Huntington’s Disease Clinical Trials Corner: August 2023
In this edition of the Huntington’s Disease Clinical Trials Corner, we expand on the GENERATION HD2 (tominersen) and on the Asklepios Biopharmaceutical/BrainVectis trial with AB-1001. We also comment on the recent findings from the PROOF-HD trial, and list all currently registered and ongoing clinic...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473124/ https://www.ncbi.nlm.nih.gov/pubmed/37483021 http://dx.doi.org/10.3233/JHD-239001 |
_version_ | 1785100213142159360 |
---|---|
author | Estevez-Fraga, Carlos Tabrizi, Sarah J. Wild, Edward J. |
author_facet | Estevez-Fraga, Carlos Tabrizi, Sarah J. Wild, Edward J. |
author_sort | Estevez-Fraga, Carlos |
collection | PubMed |
description | In this edition of the Huntington’s Disease Clinical Trials Corner, we expand on the GENERATION HD2 (tominersen) and on the Asklepios Biopharmaceutical/BrainVectis trial with AB-1001. We also comment on the recent findings from the PROOF-HD trial, and list all currently registered and ongoing clinical trials in Huntington’s disease. |
format | Online Article Text |
id | pubmed-10473124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | IOS Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-104731242023-09-02 Huntington’s Disease Clinical Trials Corner: August 2023 Estevez-Fraga, Carlos Tabrizi, Sarah J. Wild, Edward J. J Huntingtons Dis Clinical Trials Corner In this edition of the Huntington’s Disease Clinical Trials Corner, we expand on the GENERATION HD2 (tominersen) and on the Asklepios Biopharmaceutical/BrainVectis trial with AB-1001. We also comment on the recent findings from the PROOF-HD trial, and list all currently registered and ongoing clinical trials in Huntington’s disease. IOS Press 2023-07-28 /pmc/articles/PMC10473124/ /pubmed/37483021 http://dx.doi.org/10.3233/JHD-239001 Text en © 2023 – The authors. Published by IOS Press https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Trials Corner Estevez-Fraga, Carlos Tabrizi, Sarah J. Wild, Edward J. Huntington’s Disease Clinical Trials Corner: August 2023 |
title | Huntington’s Disease Clinical Trials Corner: August 2023 |
title_full | Huntington’s Disease Clinical Trials Corner: August 2023 |
title_fullStr | Huntington’s Disease Clinical Trials Corner: August 2023 |
title_full_unstemmed | Huntington’s Disease Clinical Trials Corner: August 2023 |
title_short | Huntington’s Disease Clinical Trials Corner: August 2023 |
title_sort | huntington’s disease clinical trials corner: august 2023 |
topic | Clinical Trials Corner |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473124/ https://www.ncbi.nlm.nih.gov/pubmed/37483021 http://dx.doi.org/10.3233/JHD-239001 |
work_keys_str_mv | AT estevezfragacarlos huntingtonsdiseaseclinicaltrialscorneraugust2023 AT tabrizisarahj huntingtonsdiseaseclinicaltrialscorneraugust2023 AT wildedwardj huntingtonsdiseaseclinicaltrialscorneraugust2023 |